A positive correlation could be elicited between the CCL28 serum levels during AD exacerbation and the corresponding values during remission meaning that the higher the level during acute attacks, the higher it remained after remission (r = 0.91; P < 0.0001) [Figure 5]. The gene discussed is CCL28; the disease is Alzheimer disease.